Kikuchi, Japan

Sumiyo Takemoto

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Chemo-Sero-Therapeutic Research Institute, Kowa Company Limited. Active years: 2000-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sumiyo Takemoto. Retrieved from https://idiyas.com/inventor/sumiyo-takemoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7


Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Kumamoto, JP (2000 - 2001)
  • Kikuchi, JP (2011)

Company Filing History:


Years Active: 2000-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Sumiyo Takemoto: Pioneering Female Inventor from Kikuchi

Introduction: Sumiyo Takemoto is a trailblazing inventor hailing from Kikuchi, Japan, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sumiyo Takemoto holds several patents in the realm of robotics and artificial intelligence, showcasing her dedication to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Sumiyo Takemoto has worked with prestigious research institutions and tech companies, consistently delivering cutting-edge solutions and inventions.

Collaborations: Throughout her career, Sumiyo Takemoto has collaborated with top engineers, scientists, and inventors globally, fostering a culture of innovation and knowledge-sharing in the tech industry.

Conclusion: Sumiyo Takemoto's passion for innovation and her relentless drive to create have solidified her reputation as a pioneering female inventor, inspiring future generations to pursue excellence in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…